Skip to content

The Treatment of Implant-retained Mandibular Overdentures for Edentulous Patients

A Clinical Trial on Conventional Dentures and Implant-retained Mandibular Overdentures With Respect to Oral Functionality and Quality of Life in Edentulous Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02846805
Acronym
TIMOEP
Enrollment
53
Registered
2016-07-27
Start date
2016-05-31
Completion date
2020-04-30
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous

Brief summary

The purpose of this study is to investigate to what extent IOs improve the functionality of edentulous patients and changes in quality of life and overall patient satisfaction following treatment with IOs.

Detailed description

Edentulous individuals will be selected from patients attending the prosthodontic clinic. Then, new complete dentures will be provided; in a second stage half of these subjects (randomly selected) will receive IOs. The effect of different treatment protocols on chewing ability, patient satisfaction and OHRQoL will be investigated and assessed.

Interventions

subjects will receive two-implant-retained overdentures in the mandible,and they continue wearing their complete denture in the maxilla.

Sponsors

Chufan Ma
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Being edentulous in the upper and lower jaw for at least 1 year 2. Dissatisfied or cannot function with their complete lower denture 3. Age between 40 and 75 4. Suitable bone quality as assessed radiographically (CBCT) according to Zarb's classification。

Exclusion criteria

1. Physical and mental disabilities which interfere with the maintenance of implants; 2. Severe skeletal jaw discrepancies (class III) 3. Those who have already received or lost dental implants 4. Those who abuse drugs or alcohol 5. Smoking more than 10 cigarettes a day 6. Having received radiotherapy to the head and neck region for malignancies 7. Undergoing chemotherapy 8. On long-term therapy with steroids 9. immunosuppressants or biphosphonates 10. Insulin-dependent diabetic patients and uncontrolled onset diabetic patients 11. Those affected by chronic renal or liver disease 12. Systemic and local bone disorders and pathology 13. Serious cardiac and pulmonary disorders 14. Haemophilic disorders who are susceptible for increased bleeding and tendency for post-operative infections 15. Those who are at risk of developing bacterial endocarditis 16. Immune system compromised patients, including those with HIV

Design outcomes

Primary

MeasureTime frameDescription
masticatory efficiencythree months after restoration of the implant-retained overdenturemasticatory efficiency will be measured with chwing-gum ,and the outcome will be analysed with the viewgum software

Secondary

MeasureTime frameDescription
Oral health related quality of lifethree months after restoration of the implant-retained overdentureOral health related quality of life will be measured with the Oral Health Impact Profile 14(OHIP-14).
patients' satisfactionthree months after restoration of the implant-retained overdenturepatients' satisfaction will be assessed on visual analog scales (VAS)

Countries

China

Contacts

Primary ContactChufan Ma
machufan@fmmu.edu.cn+86 29 84776128

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026